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Chapter 1: Introduction  
Articular cartilage damage in the knee is a common pathology that can affect a 
large range of ages. It is estimated that 63% of patients receiving routine arthroscopies 
are found to have articular cartilage defects.4 This type of cartilage has little blood supply; 
therefore, repair without surgery is highly unlikely. Surgical options to repair articular 
cartilage defects include autologous chondrocyte implantation (ACI), microfracture, 
osteochondral autologous transplantation (OATS), and mosaicplasty. However, a gold 
standard treatment for articular chondral defects has not been established.8 Given that 
ACI is a novel procedure, there is limited data on patient-centered functional outcomes, 
and a lack of knowledge of long-term progression in these patients. There is also limited 
research providing the appropriate data needed to establish whether this procedure entails 
better patient outcomes than other chondral defect surgeries.  
Autologous Chondrocyte Implantation (ACI) is a tissue-engineered articular 
cartilage repair procedure that patients can undergo to repair damaged articular cartilage. 
This is a two-step procedure in which the first surgical procedure involves an 
arthroscopic biopsy of healthy articular cartilage that is then sent to a cell expansion 
laboratory where the cells are allowed to replicate for 4-6 weeks. After the cartilage has 
grown, the second procedure follows and the cartilage is implanted in place of damaged 
tissue.  
 Since this is still a novel procedure, there is no set criterion for whether a patient 
should or should not get an ACI. With no predictors of a positive outcome, nor 
substantial research indicating success rates, insurance companies are hesitant in 
reimbursement. The ability to predict a successful outcome would benefit patients 
financially in regards to reimbursement. Insurance companies are moving towards 
patient-centered outcomes to review the success of surgical procedures. Determining the 
level of reimbursement is based off of the data collected, where higher success rates 
reflect more substantial reimbursement. Higher reimbursement rates would mean the 
insurance companies would cover more of the rate and require less out of pocket money 
from the patient. By using patient-centered outcomes, we can trim physician bias and 
obtain personal outcome data from the patient population. This is beneficial because 
medicine is progressing toward patient-centered and functional outcomes vs. 
objective/surgeon/ clinician-based outcomes. Patient documented success is important as 
a true measure of success for surgeons, procedures, and predicting outcomes on future 
patients. Knee surgeries are expensive, and financial support from insurance companies is 
negatively correlated with the risk of a negative outcome. If data showed patient-oriented 
success following the ACI procedure, then insurance and healthcare companies are more 
likely to provide more money for the patients.  
The purpose of this study was to evaluate patient-centered outcomes of functional 
capability and pain levels following ACI surgery, as well as compare results from 
previous studies.  
Chapter 2: Literature Review  
Surveys 
When determining the efficacy of a procedure, physiological measures are 
important but they do, however, omit the patients’ perception. Surveys allow the 
collection of more subjective patient data. This study pertains to patient surveys in the 
form of patient-centered outcomes (PCO’s). Appleby describes PCO’s as a measure of 
quality that links effectiveness with efficiency of care.18 These outcomes focus on purely 
subjective responses that more directly reflect a patients health status than physiological 
measures.     
Patient-oriented improvement following ACI surgery in this study was evaluated 
using the International Knee Documentation Committee (IKDC), global rating of change 
scale (GROC), depression self-assessment (DSA) and the visual analog scale for pain 
(VAS). The IKDC presents a variety of questions surrounding symptoms, function, and 
sports activities that are ranked from 1 to 5 or 1 to 10 point scales. Summing the scores 
and dividing by the total possible score establishes an IKDC score. The minimum 
clinically important difference for the IKDC is reported to be 6.3 at 6 months and 16.7 at 
12 months.12 
 The global rating of change (GROC) survey represents, on a -7 to +7 scale, the 
rate of change in overall functional capability. The lower end of the GROC is “a very 
great deal worse,’ while the top is “a very great deal better.” The GROC scale is used to 
quantify a patients improvement or deterioration over time usually to determine the effect 
of an intervention.13 The Depression Self-assessment (DSA) is a 20-item self reported 
instrument that consists of symptom rating scales that provide a measure of depression 
symptom frequency and cutoff score indicating a probable diagnosis of depression.16 An 
overall score out of 60 is determined with a score over 16 indicating depression. The 
VAS pain scale is used to measure pain intensity currently and at the moments where 
pain is the worst. These scales are from 0 to 100 mm. Patients with VAS pain scores of 
30 mm or less would be categorized as having mild pain, those with scores of 70 mm or 
more were categorized as having severe pain and those from 31 mm to 69 mm, moderate 
pain.14 The minimal clinically significant difference (MCSD) in VAS pain score was 
defined as the mean difference between current and preceding scores when the subject 
reported “a little worse” or “a little better” pain.14 
ACI procedure 
Chondral injuries are debilitating pathologies that can compromise the quality of 
life due to pain, swelling, and impaired mechanical movement.6 The chondral tissue 
discussed in this study is hyaline cartilage. Hyaline cartilage does not receive an adequate 
blood supply to heal, so surgical intervention is often necessary.4 The Autologous 
Chondrocyte Implantation (ACI) surgery is a two-stage operation, typically spread out 
over a 5 week time period.  First, an arthroscopic surgery is performed to obtain 200-300 
mg of healthy articular cartilage harvested from a non-weight bearing portion of the 
knee.4 The cells are then sent to a tissue-engineering laboratory for chondrocyte 
expansion.4 Once approximately10 million cells are collected, the cells are implanted 
underneath a periosteum flap obtained from the proximal end of the tibia.7 It has been 
shown that a patient following a failed microfracture surgery can benefit greatly from the 
ACI procedure because of damage to the subchondral plate.4 It is still unclear whether 
realignment procedure performed previous to or with the ACI is detrimental. In a study 
comparing the ACI procedure to mosaicplasty, an alternative approach, the ACI patients 
had significantly greater outcomes.5  
Successful outcomes 
 Evaluating ACI patients ≥ one year post-operation in overall knee condition, knee 
function, and patient symptomatology helps to establish the efficiency of the procedure.   
As shown in a study done by Micheli et al,3 84% (42 of 50) of patients were improved 36 
months postoperatively and only 6% (3 of 50) had graft failure. Failure of a graft usually 
leads to subsequent total knee replacement. Multiple studies have shown that ACI has a 
fairly low failure rate. One study with a large patient population (N=827) revealed that 
graft survival rate was 78.2% at 5 years and 50.7% at 10 years.11 Another study, Pascual-
Garrido et al,4 found that only 7.7% (4 of 52) ACI grafts resulted in failure. A similar 
study of ACI patients age 45 and older recorded a failure rate of 4.9% (3 of 54) in non-
workers compensation patients, and an overall failure rate of 14% (8 of 54).6  
Improvements in pain and overall function 
 Studies have demonstrated that ACI patients typically improve in pain and overall 
function of health. One study, of 34 patients, obtained preoperative IKDC scores where 
only 8 knees were classified as normal and 26 were classified as abnormal or severely 
abnormal.2 After 2 years, 32 of the 34 patients knees were classified as IKDC normal or 
nearly normal following the ACI procedure.2 IKDC scores showed significant 
improvement in this study. Scores went from 46.09 ± 19.3 preoperatively to 77.06 ± 17.0 









Figure 1. IKDC score: improvement from preoperative to 2 and 5 years’ follow-up.2 
  
Pascual-Garrido et al4 concluded that autologous chondrocyte implantation is a viable 
treatment option for chondral defects. This study included 62 patients and examined 
preoperative and follow-up (2-5 years) IKDC scores. The mean improvement for IKDC 
was 31-57.  
 Patients who undergo ACI surgery have been shown to experience a decrease in 
overall and functional pain levels. Gobbi et al2 reported a preoperative mean EQ VAS 
score of 56.75 ± 18 that improved to 81.47 ± 13.3 at 2-year follow-up. Another study 
demonstrated similar results with VAS pain levels >60 evident in 64% (32 0f 50) of the 
patients preoperatively, but only 4 % (2 of 50) had pain levels >60 at follow-up. 15  
 
Patient satisfaction  
One study of 56 patients ≥45 years of age who underwent cartilage repair with 
ACI.6 Rosenberger et al6 chose 45 years of age as their threshold because this is the 
common insurance age limit for ACI, despite weak supporting data. This study claims 
that results are comparable to younger ACI patients when comparing patient satisfaction, 
and four validated rating scales: Short Form-36, Modified Cincinnati Rating Scale, 
WOMAC Osteoarthritis index, and the Knee Society Score.6 At their latest available 
follow-up, 72% of patients rated themselves as good or excellent, 78% felt improved, and 
81% would again choose ACI as a treatment option (Table 1).6  




 Microfracture is a surgical substitution for the ACI procedure to revise chondral 
defects. Microfracture provides an enriched environment for tissue regeneration on the 
chondral surface by using the body's own healing abilities. After damaged cartilage has 
been removed, multiple holes are drilled in the exposed bone. Blood and bone marrow 
cells seep through and eventually form a clot that matures into firm repair tissue. Many 
long-term studies on microfracture have found increased complications compared to 
other procedures. Gudas et al10 found that 4 year microfracture postoperative failure rate 
was 41% (9 of 22). Microfracture surgery can cause lingering pain and prolonged damage 
to the subchondral plate. One study suggests that microfracture surgery may cause 
damage to the subchondral plate compromising additional revision surgery.9 Damage to 
the subchondral plate suggests the need for a second surgery, like ACI, to revise the 
defects.  
Chapter 3: Methods 
This study included 10 patients, male and female, from a local orthopedic 
practice. Subjects were asked to complete a survey packet pre-operatively, and at three, 
six, and 12 months post-surgery as part of their standard medical files. These surveys 
included the International Knee Documentation Committee (IKDC), Visual Analog Scale 
(VAS) for Pain, Depression Self-assessment (DSA), and a Global Rating of Change 
(GROC) for overall functional ability. Once IRB approval was obtained, researchers 
picked up patient survey packets and entered their data, which was de-identified. The 
IKDC survey consists of 9 small surveys; data will be summed to denote a number value 
from 0 to 87 and divided by 0.87, representing patient’s knee function. The VAS scale 
consists of a current and “when at worst” scale; these values will be collected and 
averaged to denote a number value for the patients overall pain level. The DSA is a 
survey that asks the patient to read ways they may have felt in the past week, and mark 
whether they were feelings lasting less than one day, one to two days, three to four days, 
or five-seven days. This data was summed to a value out of 60, where a number above 16 
suggests depression. The GROC scale consists of an overall and specific functional 
capabilities scale; both values were assessed individually and given a value of -7 to 7. I 
reviewed these scores for each patient and entered them into spreadsheet software for 
data analysis.  
Statistical Analysis 
All variables were analyzed with descriptive statistics and percentages of patients 
were calculated. Select variables were analyzed using paired samples t-tests. Receiver 
operator characteristic curve analysis was conducted to determine cut points for select 
variables as potential predictors of successful outcome. To determine clinically relevant 
outcomes and predictive value, further 2X2 cross tabulation analysis was used to 
calculate sensitivity, specificity, and relative risk ratios.  
 
Chapter 4: Results  
The time frame established for short-term success was determined by post-
operative surveys, which varied in time (2.7 ± 0.9 months; range: 1-4 months) following 
surgery. Patient responses to short-term global rating of change (GROC) varied greatly 
(Table 2). Post-operative GROC analysis showed that 8 patients (80%) had at least “a 
little better” overall functional capabilities, 1 (10%) had “no change,” and 1 (10%) failed 
to respond. Post-operative GROC analysis of specific capabilities showed identical 
results with 8 patients (80%) having at least “a little better” overall functional 
capabilities, 1 (10%) with “no change,” and 1 (10%) failed to respond. 
Pre-operative IKDC scores reported 3 patients as having 10-30% function, 2 with 
30-50%, 1 with 50-70%, and 2 with 70-80% function. Post-operative IKDC scores 
showed 3 patients as having 10-30% function, 5 with 30-50%, 1 with 50-60%, as well as 
1 unreported response. The difference in post-operation and pre-operation IKDC scores 
varied from better to worse (Table 3). With 1 failed response, 4 patients (40%) saw 
improvements in IKDC scores (range: 4 to 25 points). Five patients (50%) were found to 
have a decrease in IKDC scores (range: -1 to -34 points).   
Pre-DSA scores ranged from 3-23 with 1 patient considered “depressed” (score 
≥16). 8 patients (80%) scored <10, 1 (10%) scored a 12, and 1 (10%) scored a 23.  
Current VAS pain scored, pre-operatively, showed a mean pain score of 2.45 ± 
1.82 where 7 patients (70%) had pain levels between 0-3 and 3 patients (30%) had levels 
between 4-6. Post-operative current VAS scores showed a mean pain level of 1.32 ± 1.13 
where all 10 patients scored between 0-3. Short-term pain levels decreased from pre-
operation by a mean of 1.13 ± SD 2.21. 4 patients (40%) had an increase in pain levels 
between 0-1.5 points, 4 (40%) decreased by 1-3 points, and 2 (20%) decreased by 4-5 
points.  
"At worst" VAS pain levels before surgery averaged 7.6 points ± 1.37 with 4 
patients (40%) scoring between 5-7 and 6 (60%) scoring between 8-10. Post-operative "at 
worst" averaged 6.15 ± 2.7 points with 4 patients (40%) between 2-4, 2 (20%) between 5-
7, and 4 (40%) between 8-10. Pain, when at its worst, was shown to decrease by a mean 
of 1.45 ± 3.05 points with 3 (30%) who experienced an increase in pain between 0-3, 3 
(30%) with decreased levels between 0-3, 3 (30%) decreased between 4-7, as well as 1 
(10%) with no change.      
For the purpose of this study, successful short-term outcomes were established as 
a GROC score ≥3 or post-VAS pain levels ≤2. 8 patients (80%) had a successful outcome 
determined by GROC score, post-VAS score, or both. There were 8 patients (80%) that 
had success via GROC outcome and 5 patients (50%) who had success via VAS pain 
score.   
  Patients with pre-operative VAS scores ≥3 were more likely to have a successful 
short-term outcome, via GROC ≥3, with a relative risk of 1.5 (figure 2). Similarly, 
reviewing GROC scores ≥3 also showed patients with pre-IKDC scores <50 had more 
successful outcomes with a relative risk of 3. Patients with a DSA score >7 were found to 
have a 1.56 times greater chance of having a change in rating of function of ≤3 when 
compared to those who scored 7 or less on this survey (figure 2).  
Patients below the age of 40 were found to have lower pain levels (≤2) more often 
than those ≥40 years of age with a relative risk of 1.67 (figure 3). Patients ≥40 had more 






Table 2. Patient Global Rating of Change at Short-term Follow-up (range: 1-4 months; 
mean: 2.7 months; n=10).  
Table 3. Difference in Post-operation and Pre-operation IKDC scores (range: 1-4 
months; mean: 2.7 months; n=10).   
Difference in IKDC Score Statistic (n=10) 
20 to 30 points  1 (10%) 
10 to 20 points 1 (10%) 
0 to 10 points 2 (20%) 
-10 to 0 points 3 (30%) 
-20 to -10 points 1 (10%) 
-30 to -20 points 0 
-40 to -30 points  1 (10%) 
No response 1 (10%) 
 
Question Statistic Response (n=10) 
Since first starting treatment, how 
would  
   you rate your change in overall  
  
   functional capabilities   
 A great deal better 0 
 A good deal better 1 (10%) 
 Moderately better 2 (20%) 
 Somewhat better 2 (20%) 
 A little better 3 (30%) 
 Almost the same 0 
 No change 1 (10%) 
 No response 1 (10%) 
Since first starting treatment, how 
would 
  
   you rate your change in specific   
   functional capabilities   
 A great deal better 1 (10%) 
 A good deal better 1 (10%) 
 Moderately better 2 (20%) 
 Somewhat better 1 (10%) 
 A little better 2 (20%) 
 Almost the same 1 (10%) 
 No change 1 (10%) 
 No Response 1 (10%) 
Figure 2. Comparing Patient Pre-DSA, Age, and Pre-VAS Data to Short-term GROC 
Outcomes.  
 
















































Chapter 5: Discussion  
After analyzing and comparing pre- and post-operative surveys, it is evident that 
most patients experienced short-term success. For the purpose of this study, successful 
short-term outcomes were established as a GROC score ≥3 or post-VAS pain levels ≤2. 
With an 80% success rate, data suggests that the ACI procedure does elicit short-term 
success.    
Success Rate 
Since the complete recovery time for this surgery is 1 year, it must be noted that 
these short-term success rates are in a time frame that is only about 33% through post-
surgical treatment. The small change in overall function with the GROC scale was 
expected because of this. This explains the small decrease in pain levels (mean 1.13) as 
well. Patients were enduring intense rehabilitation programs and most are only just 
recently off of crutches or still using them. Function was expected to be low and pain 
levels can stem from the intense rehab as well.  
Possible Predictors  
Age, VAS pain scale, IKDC, and DSA scores, pre-operatively, were found to be 
possible predictors of a short-term successful outcome. Patients below the age of 40 
displayed a 1.67 times greater chance of experiencing pain levels ≤2 during their short-
term follow-up. According to Woodrow et al,17 pain tolerance decreases linearly with 
age, so it is relevant that younger patients would record lower pain levels. 
Patients 40 years of age or older were shown to have a 1.8 times greater chance of 
having a GROC score of ≥3 than those under the age of 40. Older patients generally have 
less function overall, so younger patients most likely felt that they had not progressed 
much in getting back to their original functional capabilities.  
Pre-VAS pain scores suggest that patients with a score of ≥3 pre-operatively will 
be 1.5 times more likely to score ≥3 on the GROC survey than those who scored <3. 
Patients experiencing more pain pre-surgery seem to be capable of noticing a greater 
change in their short-term function than those who had less pain.  
Lower functioning patients, via pre-IKDC data, shows that a patient with <50 
points is 3 times more likely to have a GROC score of ≥3. Less function pre-surgery 
suggests that the patient will have greater improvements in their function overall. If a 
patient has a low functional score, then it is understood that they will notice a greater 
change in function more than someone with a higher pre-surgical score.  
DSA data suggests that a patient with a score >7 will have a 1.56 times greater 
chance to have a negative outcome in regards to the GROC scale (≤3). A patient showing 
depressive symptoms would generally have a negative outlook on treatment and progress 
in functional capabilities. Therefore, a depressed patient would generally see their 
progression of function as slower, or less significant than those who are not depressed.  
Previous Studies 
 Success rates in this study support data collected by Micheli et al.3 Eighty-four 
percent of patients in his study reported a successful outcome, where an 80% success rate 
was reported in this study. This would suggest that throughout recovery from this 
operation, patients generally feel that they are progressing and will have a successful 
outcome. A decrease in pain levels also aligned with previous studies.  
 
Conclusion 
 With our small population size and relatively short time frame, data collected 
from this study was unable to confidently declare whether the ACI procedure is 
successful. However, our evidence shows that most patients see improvements in pre-
operative function and pain levels in an average of 2.7 months post-op. Data suggests that 
patients with pre-VAS ≥3, pre-IKDC <50, and age >40 are most likely to have a 
successful outcome in regards to improved overall functional capabilities. Also, it can be 
predicted that younger patients (<40) will have a greater chance to have a successful 
outcome with a decrease in pain levels. Conversely, a patient with a score of >7 on the 
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